DFW Capital Partners is pleased to announce that its existing portfolio company, Saol Therapeutics, has acquired to acquire three marketed hyperimmune products, WinRho® SDF (Rh0(D) Immune Globulin Intravenous (Human)), HepGam B® (Hepatitis B Immune Globulin Intravenous (Human)) and VARIZIG® (Varicella Zoster Immune Globulin (Human)) from Aptevo Therapeutics Inc. (Nasdaq: APVO). The deal includes both upfront… Read more »
DFW Capital Partners is pleased to announce that its existing portfolio company, Evolution Research Group (“ERG”), has acquired Endeavor Clinical Trials (“ECT”), of San Antonio, Texas. ECT has over 20 years of experience conducting over 185 clinical trials, specializing in post-operative pain, neuropathic pain, podiatry, and vaccine research, among others. Endeavor Clinical Trials is comprised… Read more »
DFW Capital Partners (“DFW”) today announced that Integrated Efficiency Solutions (“IES”), a new holding company, has continued its commitment to the energy solutions market with its third investment. On June 30, 2017, IES acquired Retro-Tech Systems (“RTS”) as a wholly owned subsidiary. RTS, which includes RTS Lighting, RTS Water, RTS Utility Metering, and RTS Building… Read more »
DFW Capital Partners is pleased to announce that its existing portfolio company, Superior Controls, a leading control system integrator of custom industrial automation and IT solutions, has merged with Banks Integration Group (“Banks Integration”), a leading systems integrator headquartered in Vacaville, CA outside San Francisco. The combination, which is the first investment of its kind for… Read more »
DFW Capital Partners portfolio company LRI Energy Solutions (LRI), a leading provider of performance-based energy, lighting and water efficiency services is pleased to announce the integration of Enlight Energy Efficient Lighting into the family of LRI companies helping save energy and water across the United States. Enlight Energy Efficient Lighting, Inc. (Enlight) is an energy… Read more »
With 2017 now in full swing, we wanted to share with you the highlights of our very busy 2016! The past year has been one of DFW’s most active. In April, we held a first and final closing on our fifth dedicated investment partnership. DFW Capital Partners V, LP was raised in less than three months, securing… Read more »
DFW Capital Partners (“DFW”) is pleased to announce that it recently completed an equity investment in Children’s Dental Health Associates (“CDHA Holdings, LLC” or “CDHA”). CDHA is a dental service organization, providing management and support services to pediatric dentists throughout the state of Pennsylvania. The Company’s CEO and founder, Dr. Eric Felix, management, and each… Read more »
DFW Capital Partners (“DFW”) announced today a strategic investment in Lighting Retrofit International, LLC (“LRI” or the “Company”). LRI is a portfolio company of Arborview Capital (“Arborview”), which previously invested into LRI in 2010. LRI is DFW’s first portfolio investment in its newest fund, DFW Capital Partners V, LP, which held its final closing in… Read more »
DFW Capital Partners is pleased to announce that its existing portfolio company, Evolution Research Group (“ERG”), has acquired Clinical Pharmacology of Miami, LLC (“CPMI”), a clinical investigative site conducting research protocols for pharmaceutical/biotech companies and a leader in specialty population Phase I trials. With this acquisition, ERG has now completed three strategic add-on acquisitions since… Read more »
DFW Capital Partners (“DFW”) announced today that it has held a first and final closing of DFW Capital Partners V, L.P. (“Fund V”), an investment partnership dedicated to making control investments in lower-middle market service companies. The fund was oversubscribed and exceeded its fundraising target. Fund V is capitalized with $360 million in commitments, primarily from institutional… Read more »
